Helping older cancer survivors manage depression through behavioral activation.
Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes
This study is looking to improve depression treatment for older adults who have survived cancer by making a therapy called Behavioral Activation more engaging and accessible, and it will involve feedback from both survivors and healthcare providers to make it better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11047670 on NIH RePORTER |
What this research studies
This research focuses on older adult cancer survivors who are experiencing significant depression. It aims to adapt a treatment called Behavioral Activation (BA) to better engage these individuals in effective depression care. The study will gather feedback from cancer survivors and healthcare providers to refine the treatment approach and identify barriers to accessing care. By using a combination of pilot testing and randomized control trials, the research seeks to implement a practical solution for improving mental health in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors aged 65 and older who are at least one year post-treatment and experiencing symptoms of depression.
Not a fit: Patients who are not cancer survivors or those who do not meet the age and treatment timeline criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide older cancer survivors with effective strategies to manage their depression, improving their overall quality of life.
How similar studies have performed: Previous research has shown promise in using behavioral activation for depression treatment, particularly in older adults, indicating a potential for success in this approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Saracino, Rebecca — Sloan-Kettering Inst Can Research
- Study coordinator: Saracino, Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.